Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 2
Tick-Borne Encephalitis Virus (TBEV) non-structural protein 1 (NS1) is a glycoprotein that plays a pivotal role in the virus's replication and immune evasion. NS1 is expressed during acute TBEV infection and is secreted into the host's bloodstream. It is involved in modulating host immune responses, which can influence the severity of the infection. NS1-specific antibodies can be detected, serving as a marker for natural infections and aiding in the diagnosis of TBEV in vaccinated individuals. Eukaryotic expression systems are commonly employed to produce recombinant NS1, which is used in various immunological assays and research. The NS1 protein not only serves as a target for diagnostic purposes but also presents opportunities for developing therapeutic inhibitors. Research has shown that NS1 can affect dendritic cell effector functions, indicating its broader role in immune modulation. As TBEV causes severe neurological disease, understanding and targeting NS1 is crucial for improving diagnostic and therapeutic strategies.
仅用于科研。不用于诊断过程。未经明确授权不得转售。